Company Overview
More
Micro Chuangxintong Medical Technology Co., Ltd. is a Chinese investment holding company mainly engaged in the medical device industry. The company is mainly engaged in the R & D and commercialization of transcatheter and surgical solutions in the field of valvular heart disease. The company's main products include the first generation transcatheter aortic valve implantation (TAVI) product "VitaFlow" and the second generation TAVI product "VitaFlow II". The company mainly does business in the domestic market.
CEO： Qiyi Luo
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
02160 CARDIOFLOW-B
2.220+0.080+3.74%
YOY
Do not show
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(FY)2019/12/31
Assets
Current assets
Inventory
22.08%
82.73M
--
64.6M
37.67%
67.77M
188.2%
49.22M
Accounts receivable
188.02%
113.48M
--
55.76M
58.12%
39.4M
161.65%
24.92M
Cash and equivalents
261.09%
2.21B
--
2.78B
460.55%
612.47M
116.71%
109.26M
Secured deposit
58985.23%
192.03M
--
325K
0%
325K
0%
325K
Total current assets
261.1%
2.6B
--
2.9B
291.86%
719.97M
137.54%
183.73M
Non-current assets
Property, plant and equipment
292.19%
267.17M
--
92.13M
59.29%
68.12M
25.47%
42.77M
Associated company interest
--
176.74M
--
--
--
--
--
--
Interests in Joint Venture
-2.32%
33.22M
--
33.57M
-4.42%
34.01M
1.41%
35.58M
Financial assets at fair value-non-current assets
-57.48%
21.05M
--
--
--
49.51M
--
--
Intangible assets
1.96%
238.75M
--
242.43M
5.25%
234.17M
13.28%
222.49M
Other illiquid assets
294.29%
25.27M
--
118.5M
-89.55%
6.41M
3.6%
61.33M
Total non-current assets
94.33%
762.19M
--
486.62M
8.29%
392.21M
11.51%
362.17M
Total assets
202.29%
3.36B
--
3.38B
103.73%
1.11B
35.75%
545.9M
Liabilities
Current liabilities
Accounts payable
47.32%
126.78M
--
84.21M
143.58%
86.06M
-68.16%
35.33M
Tax payable
--
--
--
326K
--
--
--
--
Bank loans and overdrafts
--
--
--
--
--
--
--
20M
Derivative financial instrument-current liabilities
--
--
--
--
--
60.37M
--
--
Financial lease liabilities-current liabilities
381.8%
34.7M
--
8.87M
-0.65%
7.2M
70.24%
7.25M
Special items of current liabilities
-99.77%
2.96M
--
23K
293.06%
1.28B
--
325.16M
Total current liabilities
-88.51%
164.43M
--
93.43M
269.24%
1.43B
236.55%
387.74M
Net current assets
442.18%
2.44B
--
2.8B
-248.86%
-711.73M
-438.77%
-204.01M
Total assets less current liabilities
1100.76%
3.2B
--
3.29B
-302.02%
-319.51M
-44.88%
158.16M
Non-current liabilities
Financial lease liabilities-non-current liabilities
954.33%
90.94M
--
5.19M
-24.21%
8.63M
-5.63%
11.38M
Deferred income-non-current liabilities
-33.63%
2.25M
--
3.56M
-2.59%
3.39M
135.14%
3.48M
Derivative financial instruments-non-current liabilities
-42.16%
7.9M
--
12.97M
19.21%
13.66M
--
11.46M
Total non-current liabilities
293.77%
101.08M
--
21.72M
-2.45%
25.67M
94.36%
26.32M
Total liabilities
-81.78%
265.52M
--
115.15M
251.97%
1.46B
221.59%
414.06M
Total assets less total liabilities
997.05%
3.1B
--
3.27B
-361.81%
-345.18M
-51.77%
131.84M
Total equity and non-current liabilities
1100.76%
3.2B
--
3.29B
-302.02%
-319.51M
-44.88%
158.16M
Equity
Share capital
38.33%
83K
--
83K
-3.23%
60K
-99.54%
62K
Reserve
996.87%
3.1B
--
3.27B
-361.98%
-345.24M
-49.31%
131.78M
Legal reserve
996.87%
3.1B
--
3.27B
-361.98%
-345.24M
-49.31%
131.78M
Shareholders' Equity
997.05%
3.1B
--
3.27B
-361.81%
-345.18M
-51.77%
131.84M
Total equity
997.05%
3.1B
--
3.27B
-361.81%
-345.18M
-51.77%
131.84M
Total equity and total liabilities
202.29%
3.36B
--
3.38B
103.73%
1.11B
35.75%
545.9M
Currency Unit
CNYCNYCNYCNY
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor
KPMG accounting firm--KPMG accounting firmKPMG accounting firm
Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.
The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%